Sudan renews medtech prospects:
This article was originally published in Clinica
International healthcare efforts in the Darfur region of Sudan are set to resume, after the government signed a series of security and humanitarian access agreements yesterday. The move is in response to widespread condemnation of the severe social instability in the region. The situation has essentially obviated the calls made in July to meet shortfalls in medical supplies and diagnostic services and hospital infrastructures (see Clinica No 1117, p 13). International efforts were expected to resume last week, after the government signed a series of security and humanitarian access agreements, in response to widespread condemnation of the severe social instability in the region. The UN Security Council met on November 18, in Nairobi, Kenya, to discuss the situation and consider sanctions.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.